G01N 2410/08
Cyclosporins and related peptides
G01N2410/08 (Cyclosporins and related peptides) appears on 8 US grants and 8 published applications in this corpus.
Search patents in G01N- Granted patents
- 8
- Published applications
- 8
- Assignees
- 5
- Inventors
- 18
- Latest grant
- 16 Mar 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 2 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods and reagents for analyzing protein-protein interfaces16 Mar 2021US 10,948,495 B2Revolution Medicines, Inc.
- Methods and reagents for analyzing protein-protein interfaces5 Nov 2019US 10,466,249 B2Revolution Medicines, Inc.
- Methods and reagents for analyzing protein-protein interfaces5 Jun 2018US 9,989,535 B2Warp Drive Bio, Inc.
- Screening methods for the identification of anti-HIV compounds employing a cyclosporine-specific monoclonal antibody that cross-reacts with HIV-1 p2423 Jan 2001US 6,177,253 B1The Trustees of Columbia University in the City of New York
- Assays for measuring immunosuppressants by reporter gene expression27 Apr 1999US 5,897,990 ANovartis AG
- Methods and reagents for analyzing protein-protein interfaces13 Mar 2025US 2025/0085291 A1Revolution Medicines, Inc.
- Methods and reagents for analyzing protein-protein interfaces30 Dec 2021US 2021/0405060 A1Revolution Medicines, Inc.
- Methods and reagents for analyzing protein-protein interfaces13 Sep 2018US 2018/0259535 A1Warp Drive Bio, Inc.
- Methods and reagents for analyzing protein-protein interfaces6 Sep 2018US 2018/0252726 A1Warp Drive Bio, Inc.
- Methods and reagents for analyzing protein-protein interfaces6 Apr 2017US 2017/0097359 A1Warp Drive Bio, Inc.
Most cited
By later US patents
- Derivatives of cyclosporina A, antibodies directed thereto and uses thereof31US 5,350,574 AThe Trustees of Columbia University in the City of New York · 1994
- Methods and reagents for analyzing protein-protein interfaces24US 9,989,535 B2Warp Drive Bio, Inc. · 2018
- Methods and reagents for analyzing protein-protein interfaces23US 10,466,249 B2Revolution Medicines, Inc. · 2019
- Derivatives of cyclosporine A, antibodies directed thereto and uses thereof17US 5,405,785 AThe Trustees of Columbia University in the City of New York · 1995
- Method for the detection of HIV-1 using a cyclosporine-specific monoclonal antibody that reacts with the P24 Gag protein16US 5,604,092 AThe Trustees of Columbia University in the City of New York · 1997